- Generics contend in PPIs
- Topco institutes OTC substitution program for generic Rx
- PL Developments to sell, distribute store-brand generic Zegerid OTC
- New P&G initiative may create clash of the OTC titans
- Takeda: Edarbyclor statistically superior in reducing blood-pressure levels among hypertension patients
WOODCLIFF LAKE, N.J. — Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.
Par announced that it had entered a supply and distribution agreement through subsidiary Par Pharmaceutical to distribute an authorized generic version of Atacand HCT (i.e., candesartan cilexetil and hydrochlorothiazide) tablets.
An authorized generic is a branded drug marketed under its generic name at a discounted price, usually through a third-party company.
Par has started shipping the drug in the 16/12.5-mg, 32/12.5-mg and 32/25-mg strengths. Atacand HCT has annual sales of aboutt $61 million, according to IMS Health.